{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:16:45Z","timestamp":1761862605332},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ygyno.2006.09.023","type":"journal-article","created":{"date-parts":[[2006,10,28]],"date-time":"2006-10-28T11:18:12Z","timestamp":1162034292000},"page":"612-616","source":"Crossref","is-referenced-by-count":22,"title":["Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer"],"prefix":"10.1016","volume":"104","author":[{"given":"H.G.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Henze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Karbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thomssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2006.09.023_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-1438.2005.00430.x","article-title":"AGO Ovarian Committee; AGO Ovarian Cancer Study Group (AGO-OVAR). The role of surgery in recurrent ovarian cancer","volume":"15","author":"Pfisterer","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.09.023_bib2","first-page":"#1810","article-title":"Topotecan vs treosulfan in recurrent ovarian cancer after initial therapy with platinum and paclitaxel. A prospective randomized phase III study","author":"Meier","year":"2003","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.ygyno.2006.09.023_bib3","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.023_bib4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based, chemotherapy in women with relapsed ovarian cancer: the ICON 4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2006.09.023_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1525-1438.2005.15355.x","article-title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","volume":"15","author":"Pfisterer","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.09.023_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ygyno.2005.07.020","article-title":"A phase I\/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma","volume":"99","author":"Rose","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.023_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.bjc.6602879","article-title":"Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second-or third-line treatment in patients with relapsed ovarian cancer: a phase I\/II trial","volume":"94","author":"Rothermundt","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.09.023_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage-designs for phase II clinical trials","volume":"10","author":"Simon","year":"1998","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ygyno.2006.09.023_bib9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl 8","key":"10.1016\/j.ygyno.2006.09.023_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 consensus statement on the management of ovarian cancer: final document of the 3rd International Gynecologic Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.023_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00001813-200009000-00003","article-title":"Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthra-cyclines and paclitaxel: partial cross resistance between paclitaxel and docetaxel","volume":"11","author":"Lin","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ygyno.2006.09.023_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10549-004-2184-0","article-title":"Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer","volume":"89","author":"Yonemori","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2006.09.023_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/annonc\/mdj097","article-title":"A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients","volume":"17","author":"Viens","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2006.09.023_bib14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djh323","article-title":"Phase III randomized trial of docetaxel\u2013carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma","volume":"96","author":"Vasey","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2006.09.023_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806007906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806007906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T20:32:46Z","timestamp":1587241966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806007906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0090825806007906"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.09.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}